Top

Tag: drug manufacturing


Industry, Vaccines

Hospitals scramble to get ready for coronavirus vaccines

November 19, 2020

Via: Biopharma Dive

Hospitals across the country are ramping up their efforts to figure out how to store, track and administer coronavirus vaccine doses as confidence grows that an effective vaccine could soon become available. Hospitals will play a key role once a […]


Cell and Gene Therapy, Industry, News

Catalent Appoints Open Innovation, Biologics, Cell and Gene Therapy VP

November 19, 2020

Via: Contract Pharma

Catalent has appointed Behzad Mahdavi, Ph.D., MBA, as Vice President of Open Innovation, Biologics, Cell and Gene Therapy. In this new role, Dr. Mahdavi will join a team of experts in Catalent’s Science and Technology Group that works with customers […]


Manufacturing, Research and Development

AB2 Bio and WuXi Biologics Collaborate on Orphan Drug Manufacture

October 30, 2020

Via: Genetic Engineering and Biotechnology News

AB2 Bio, a Swiss clinical-stage biotech company developing therapies for the treatment of severe systemic autoinflammatory diseases, and WuXi Biologics agreed to collaborate to set up and accelerate commercial-scale manufacturing of Tadekinig alfa, AB2 Bio’s recombinant IL-18 binding protein. AB2 […]


Industry, Vaccines

Trump administration to require insurers cover coronavirus vaccines

October 29, 2020

Via: Biopharma Dive

A third surge in COVID-19 cases in the U.S., with many hospital systems warning of strained capacity, underscores how much hopes for a return to normalcy could hinge on a safe and effective vaccine. More than 40 vaccines are in […]


Industry, Manufacturing, Research and Development, Vaccines

Medigene and Cytovant Sign Vaccine Manufacturing Deal

October 27, 2020

Via: Genetic Engineering and Biotechnology News

Medigene, clinical stage immuno-oncology company focusing on the development of T cell immunotherapies for cancer, entered into a service agreement with Cytovant Sciences to support process development activities for the manufacturing of dendritic cell (DC) vaccines. The deal builds on […]


Manufacturing, Research and Development

CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin

October 20, 2020

Via: Contract Pharma

CNS Pharmaceuticals Inc.’s U.S. manufacturer, Pharmaceutics International Inc., has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable. “Completing the manufacturing […]


Manufacturing, Research and Development

More Manufacturing, More Jobs – Abzena drops $60 Million on New San Diego Facility

October 12, 2020

Via: BioSpace

CDMO Abzena is poised for massive growth with the completion of its new $60 million facility for Phase III and commercial cGMP manufacturing. The 50,000 sqft “Lusk” facility is a welcome addition to the company’s San Diego, CA site, allowing […]


FDA, Regulations

Alkermes’ Schizophrenia Drug Passes FDA Advisory Committee Hurdle

October 12, 2020

Via: BioSpace

Shares of Alkermes were up more than 12% in pre-market trading after the Ireland-based company announced late Friday that its schizophrenia drug was overwhelmingly supported by an advisory committee for the U.S. Food and Drug Administration (FDA). A joint meeting […]


Industry, Manufacturing, Research and Development, Vaccines

Rentschler Contributes to COVID-19 mRNA Vaccine Manufacture

October 9, 2020

Via: Genetic Engineering and Biotechnology News

Rentschler Biopharma agreed to serve as CDMO partner for BioNTech whereby Rentschler Biopharma will be responsible for key aspects of cGMP drug substance manufacturing of BNT162b2, the mRNA-based vaccine against SARS-CoV-2 that is being developed by Pfizer and BioNTech, and […]


Industry, Vaccines

Vaccines Market: Emergence of New Selling Points to Aid Market Growth

October 2, 2020

Via: BioSpace

The demand within the global market for vaccines has been rising on account of advancements in the field of medical therapy and disease prevention, finds Transparency Market Research (TMR). There is a high probability of new vendors emerging in the […]


Industry, News, Vaccines

Trump, Biden spar over COVID-19 vaccines at debate. Will it help public trust in the process?

September 30, 2020

Via: FiercePharma

With tens of millions of Americans tuned in to Tuesday’s presidential debate, the race for a COVID-19 vaccine took center stage in a big way. President Donald Trump said we’re “weeks away” from a working shot, while Democratic nominee Joe […]


Manufacturing, Research and Development

The Future of Drug Discovery

September 29, 2020

Via: Genetic Engineering and Biotechnology News

For far too long, cell culture experiments lacked dimensionality and not abstractly, but in the actual physical sense. Scientists were forced to grow their cells in only two dimensions, creating monolayers that are unrepresentative of true in vivo conditions. But […]